Expression of the melanoma antigen‐encoding gene in human lung cancer

Background and Objectives: We surveyed expression of melanoma antigen‐encoding genes in lung cancer because of promising implications for immunotherapy.

[1]  N. Cascinelli,et al.  Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3 , 1995, International journal of cancer.

[2]  K. Mimori,et al.  Human esophageal carcinomas frequently express the tumor‐rejection antigens of MAGE genes , 1995, International journal of cancer.

[3]  K. Mimori,et al.  The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma. , 1995, Gastroenterology.

[4]  M. Hirohata,et al.  Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. , 1995, Cancer research.

[5]  J. Renauld,et al.  Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes , 1995, Immunological reviews.

[6]  J. Patard,et al.  Expression of mage genes in transitional‐cell carcinomas of the urinary bladder , 1995, International journal of cancer.

[7]  T. Eberlein,et al.  Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Coulie,et al.  A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3 , 1994, European journal of immunology.

[9]  P. Bruggen,et al.  Autologous cytolytic T lymphocytes recognize a MAGE‐1 nonapeptide on melanomas expressing HLA‐Cw* 1601 , 1994, European journal of immunology.

[10]  J. Becker,et al.  A member of the melanoma antigen‐encoding gene (MAGE) family is expressed in human skin during wound healing , 1994, International journal of cancer.

[11]  K. Sakaguchi,et al.  Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Brasseur,et al.  Expression of mage genes by non‐small‐cell lung carcinomas , 1994, International journal of cancer.

[13]  P. Romero,et al.  Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes , 1994, The Journal of experimental medicine.

[14]  P. Coulie,et al.  The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1993, The Journal of experimental medicine.

[15]  P. Romero,et al.  The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. , 1993, International journal of cancer.

[16]  P. Chomez,et al.  Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. , 1992, International journal of cancer.

[17]  T. Sasazuki,et al.  HLA-A and DPB1 loci confer susceptibility to Graves' disease. , 1992, Human immunology.

[18]  Catia,et al.  A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E , 1992, The Journal of experimental medicine.

[19]  P. Chomez,et al.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.

[20]  C. Mountain.  The new International Staging System for Lung Cancer. , 1986, The Surgical clinics of North America.